SPOTLIGHT -
EP. 1: Overview of Novel Therapy for Advanced-Stage NSCLC
EP. 2: Advanced-Stage NSCLC: Overall Survival Data From FLAURA
EP. 3: LIBRETTO-001: Targeting RET Fusions in Advanced-Stage NSCLC
EP. 4: Updated Data in Stage IV NSCLC: CheckMate-227
EP. 5: Metastatic NSCLC: Interpreting Data From NEPTUNE
EP. 6: Future Directions in Lung Cancer Management
EP. 7: Targeted Therapy for KRAS p.G12C NSCLC
EP. 8: Extensive-Stage SCLC: Potential in the CASPIAN Trial
EP. 9: Expanding the NSCLC Armamentarium: IMpower131
EP. 10: MET as a Clinical Target in Lung Cancer
EP. 11: Novel Lung Cancer Therapy: Future Improvements and Challenges
Further Understanding of Immune Mechanisms in Tumor Microenvironment Is Key to Advancing Immunotherapy in Solid Tumors
Navigating Systemic Therapy for RCC: Balancing Risk Status and Response
ADCs, Novel Targets Represent Next Wave of Treatment Advances in mCRPC
Precision Medicine in Prostate Cancer Care: Keeping Up With Evolving Guidance for Testing and Decision Making
